-transparent.png){kind=logo}
Eleven hybridoma cell lines producing mouse monoclonal antibodies (mAbs) against human parvovirus B19 were established. Their specificity was as follows. Approximately 5% of fetal erythroid cells inoculated with B19 reacted with all the mAbs and with anti-B19 positive human serum, but not with negative serum by indirect double immunofluorescence staining. All the mAbs recognized both VP-1 (84 kDa) and VP-2 (58 kDa) capsid proteins of B19 virions propagated in vitro and in vivo by Western blotting, and immunoprecipitated B19 virions.
Related Publications
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
March 1999,
Journal of virology,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
January 1999,
Enfermedades infecciosas y microbiologia clinica,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
March 2020,
Molecular medicine reports,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
April 2007,
Autoimmunity reviews,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
January 1994,
Journal of child neurology,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
January 1994,
Revista cubana de medicina tropical,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
September 1993,
The Journal of infectious diseases,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
April 1996,
Acta obstetricia et gynecologica Scandinavica,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
January 2018,
Journal of immunoassay & immunochemistry,
N Yaegashi, and
K Tada, and
H Shiraishi, and
T Ishii, and
K Nagata, and
K Sugamura
September 2002,
Journal of immunological methods,
